TAO Synergies Inc. (TAOX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.7x

Market Cap

$29.07M

MomentumView details →

1D Return

−4.07%

YTD Return

+2.85%

RSI (14)

50.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.7x

Market Cap

$29.07M

RSI (14)

50.9

MomentumView details →

1D Return

−4.07%

YTD Return

+2.85%

ProfitabilityView details →

Gross Margin

99.90%

Net Margin

−2155.49%

EBITDA Margin

−1084.84%

ROE (TTM)

−96.28%

ROA (TTM)

−78.90%

Asset Turnover

0.03x

GrowthView details →

Revenue YoY

—

EPS YoY

+80.00%

FCF YoY

−25.35%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+19.84%

EBITDA YoY

−20.78%

EarningsView details →

EPS (Actual)

−$1.83

EPS Surprise

85.65%

Beats (12Q)

2/12

Next Q EPS Est

−$12.75

Avg Surprise (4Q)

91.02%

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

19.99x

Quick Ratio

19.99x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

772499.00

Net Income (TTM)

−16.65M

Op. CF (TTM)

−6.20M

Next earningsDec 2, 2026 →

Latest newsMore news →

No recent news for TAOX.

Similar companies

Galecto, Inc.GLTO Estrella Immunopharma, Inc.ESLA Radiopharm Theranostics LimitedRADX Sangamo Therapeutics, Inc.SGMO Barinthus Biotherapeutics plcBRNS BriaCell Therapeutics Corp.BCTX Find similar companies →

Latest newsMore news →

No recent news for TAOX.